查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1848666

介入放射学产品市场​​（按产品类型、应用、最终用户和分销管道）—全球预测 2025-2032

Interventional Radiology Products Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年介入放射学产品市场​​将成长至 198.8 亿美元，复合年增长率为 6.60%。

主要市场统计数据
基准年2024年 119.2亿美元
预计2025年 127亿美元
预测年份：2032年 198.8亿美元
复合年增长率（%） 6.60%

关于设备创新、临床需求和不断变化的护理环境如何重塑全球介入性放射学生态系统的权威介绍。

介入放射学在临床需求、设备创新和医疗体系转型的交会中不断发展。由于成像、能量传输和栓塞化学技术的进步，微创手术如今能够治疗更广泛的病症。临床医生越来越青睐有针对性的干预措施，以降低手术併发症发生率并缩短恢復时间，这重新定义了导管室和混合手术室对各种设备的需求。

本产品涵盖多种产品，包括热消融平台、血管成形术用气球、导管、栓塞剂、栓塞弹簧圈、导管导引线、血管闭合系统和支架技术。在这些类别中，微波和射频消融术、液体和颗粒栓塞剂以及颈动脉和周边支架设计等微专业技术创造了独特的临床价值提案。应用范围涵盖神经血管手术（包括动脉瘤管理和中风血栓切除术）、肿瘤介入（包括经动脉化疗栓塞和肿瘤切除）、疼痛管理技术以及各种血管介入治疗。

最终用户范围广泛，从医院到门诊手术中心再到诊所，每个用户都有其独特的手术量、购买行为和固定设备限制。通路，无论是依赖直销模式或分销商网络，都会进一步影响产品采用曲线。总而言之，这些因素构成了以下分析的基础，并为设备创新、向护理环境的过渡以及商业化策略如何决定竞争优势和临床影响奠定了基础。

影像引导创新、门诊病人转变、数位整合和供应链弹性将如何改变临床应用和商业策略

一些变革性的变化正在发生，它们正在重新定义介入放射学的格局，并改变产品开发和商业化的轨迹。首先，影像导引和导航系统的成熟提高了手术的精确度，使得更小的设备能够更安全地治疗更复杂的解剖结构。同时，能量传递方式和栓塞材料也日益复杂，支持从一次性器械转向整合影像、消融和栓塞功能于一体的一体化治疗平台的转变。

随着手术流程向门诊病人和门诊环境的转变，对紧凑、经济高效的系统和精简工作流程的需求正在加速成长。这种转变与最终用户的购买偏好和资本配置相互影响，迫使製造商重新思考产品外形规格和服务模式。同时，包括程序分析和设备连接在内的数位增强技术正逐渐成为长期临床医生参与和上市后监测的差异化因素。

供应链弹性和监管预期也在改变。製造商正在投资本地製造和品质体系，以降低中断风险，而医疗保健系统则要求更有力的临床效益和成本效益证据。这些变化既带来了限制，也带来了机会：缩短了那些展现出明确价值的解决方案的采用时间，同时也增加了缺乏差异化临床优势的商品化产品的门槛。

评估累积关税变化如何影响介入设备价值链中的区域製造策略、定价压力和采购行为

近期的关税变化对介入器械价值链产生了累积影响，促使製造商和采购商重新评估其采购和成本结构。不断上升的关税和贸易摩擦推高了进口零件和成品的到岸成本，迫使製造商重新评估其供应商网路、材料选择和区域製造布局。因此，企业面临策略选择：消化更高的单位成本，重新设计产品以适应替代零件，或将生产转移到更靠近终端市场的地方。

这些压力也会波及到分销模式。由于医院和门诊中心会严格审查采购财务状况，直销机构可能面临利润压缩和采购週期延长的问题，而分销商主导的管道则可能面临库存重新定价和合约重新谈判的困境。临床医生和采购团队将优先考虑能够缩短手术时间并降低整体事件成本的多功能平台和解决方案，从而以已证实的临床和经济效益抵消不断上涨的设备价格。

对此，製造商可以采取适应性定价策略，达成长期供应协议，并寻求区域製造伙伴关係，以稳定其成本结构。同时，更有力的临床证据和结果记录将成为在采购审议中维护定价和证明产品选择合理性的重要工具。总而言之，这些因应措施将为介入医疗设备创造一个更具弹性、区域均衡的製造和商业模式。

关键细分洞察概述了产品模式、临床用途、医疗保健环境和分销动态如何相互影响以形成采用和商业化

详细的细分揭示了临床需求和机会在产品类型、应用、最终用户通路和通路之间的交汇点。微波和射频系统提供独特的消融特性，影响肿瘤消融通讯协定；而血管成形术球囊、导管、导管导引线和支架则满足了机械再灌注的需求。栓塞疗法包括能够远距离穿透的液体栓塞剂和提供可控闭塞的颗粒栓塞剂；支架设计也分为颈动脉保护型和周边支架型。

肿瘤治疗采用经动脉化疗栓塞术和肿瘤消融术，这依赖栓塞剂和能源来源的协同作用。疼痛管理程序需要精准的病灶定位，尽量减少附带组织损伤。血管介入治疗涵盖多种急性和慢性适应症，这些适应症会影响器械规格和辅助性治疗。

最终使用者的购买行为和治疗环境各不相同：医院通常偏好提供全方位服务支援的综合平台；门诊手术中心寻求紧凑、经济高效且优化吞吐量的系统；诊所则优先考虑能够当天完成手术且结果可预测的设备。经销商的选择（直销还是分销商）会影响售后服务预期、培训承诺和库存管理，进而影响製造商的商业营运和培训投资结构。

将临床需求、监管复杂性和製造重点与全球主要市场的可行商业化路径连结起来的区域情报

区域动态对设备设计、监管策略和商业化计画有着强大的影响。在美洲，医疗系统越来越注重基于价值的医疗服务以及向门诊病人的转型，这推动了对成本效益高、手术吞吐量高的医疗设备的需求。大型医疗系统也重视包括培训和长期服务协议在内的采购伙伴关係。

在欧洲、中东和非洲，法规环境和报销架构呈现一系列要求，这些要求重视临床证据和互通性。采购週期可能更长且更加分散，但对于能够满足多样化临床需求、同时符合区域标准和本地製造要求的设备而言，仍有机会。此外，一些市场的医疗保健能力限制正在加速采用微创手术，以减少住院时间和加护治疗的使用率。

亚太地区的特点是基础设施投资快速成长、治疗量不断扩大以及中阶对先进疗法的需求不断增长。本地製造能力和伙伴关係通常决定市场准入，而定价和服务模式的灵活性则可能成为关键的差异化因素。在整个地区，临床证据、监管檔案和供应链策略的实际本地化对于将临床兴趣转化为持续应用至关重要。

公司和竞争情报表明平台策略、伙伴关係和证据主导的商业化将决定介入设备市场的永续优势

企业策略正日益转向平台整合、集中研发投入和选择性伙伴关係，以加速临床应用。主要企业优先考虑整合影像、治疗交付和资讯服务的跨职能产品组合，而新兴企业则瞄准技术差异化与临床需求交汇处的利基市场。设备原始设备製造商 (OEM) 和软体供应商之间的合作正在不断扩展，创造出支援手术规划、术中指导和上市后结果追踪的互联解决方案。

虽然併购仍是取得互补技术和基本客群的战术性途径，但收购者更重视与现有服务模式和监管框架的契合。製造外包和策略外包可以降低资本强度，但需要严格的品质监督以保持设备的可靠性。早期投资于临床证据产生和现场培训的公司往往能够获得持续的临床医生忠诚度并获得顺利的采购核准。

从商业性角度来看，那些根据手术时间、住院时间和重复干预次数的减少情况调整定价模式的公司，将创造更强大的价值提案。此外，随着医疗服务从传统医院转移，那些为门诊和诊所环境建立可扩展支援基础设施的公司，也将获得成长。最终，一家公司在研发优先顺序、通路管理和证据开发方面的敏捷性将决定其在这个不断变化的市场中的竞争地位。

为产业领导者提供可行的策略建议，以增强供应弹性、加速门诊病人采用并将主导临床价值收益

产业领导者应优先考虑一系列切实可行的行动，以平衡短期韧性与长期成长。首先，实现製造和供应链布局多元化，以降低贸易中断带来的风险，并满足特定地区的监管要求。此策略应包括关键零件的双重采购、高风险产品的选择性近岸外包以及供应商风险分担安排，以保障供应的连续性。

其次，我们将投入资金，产生能够明确将医疗设备性能与患者治疗结果以及整个治疗过程的经济效益联繫起来的临床证据。高品质的註册登记、务实的临床试验以及强大的上市后监测，将促进更有效的报销对话，并支持其在价值驱动型医疗保健系统中的应用。第三，为了因应门诊病人移动化的趋势，我们将重组产品系列，开发紧凑型、轻服务平台，在维持临床有效性的同时，减轻门诊中心和诊所的资本和营运负担。

第四，我们将强化通路策略，根据当地市场实际情况调整直销和分销模式，并确保培训和服务能力符合最终用户的期望。第五，我们将利用数位化工具进行程序分析、远端培训和设备连接，以深化临床医生的参与度并产生经常性业务收益。最后，我们将采用自适应定价和合约框架，使商业性条款与已证实的临床价值保持一致，从而在价格敏感的环境中实现更可预测的采购结果。

由临床医生主导的透明调查方法，结合主要相关人员的参与、次要证据的综合和严格的三角测量来检验策略见解

调查方法结合了初步定性研究、二手资料整合和严格的三角检验，以确保研究结果基于临床现实和商业性实践。主要输入包括与执业干预医师、采购主管、医院管理人员、门诊手术中心营运人员和经销商合作伙伴进行结构化访谈，以掌握关于临床需求、采购驱动因素和服务期望的第一手观点。专家小组和临床医生顾问委员会负责检验临床趋势和设备性能特征。

二级研究整合了同行评审文献、临床註册、监管申报和产品技术文檔，以绘製技术属性和过往应用轨迹。在可取得的情况下，程式编码趋势和已发表的结局资料可用于临床路径评估，而供应链流程和贸易模式分析可用于製造和分销风险评估。数据透过多个资讯来源进行交叉检验，并与主要相关人员的回馈进行交叉引用，以减少偏差。

此细分框架系统地应用于产品、应用、最终用户和分销等维度，以识别临床需求与商业性可行性之间的整合领域。限制和假设均清楚记录，并进行敏感度检验，以检验不同情境如何影响策略意义。随着新的临床证据和政策发展的出现，鼓励相关人员参与，不断改善见解。

整合临床、商业和管理向量的明确结论，以确定不断发展的介入治疗的胜利策略

这份全面的分析报告强调，市场正处于动态转型之中，其特征是技术日益成熟，医疗环境向低成本转型，以及对弹性商业和製造模式的需求。能够平衡手术效果和营运效率的设备创新，很可能会引起临床医生和采购团队的浓厚兴趣。同时，地缘政治和贸易因素也推动了多元化供应链和在地化市场策略的重要性。

成功的企业将在于能够将可靠的临床证据与适应性强的产品平台相结合，提供令人信服的整体护理成本 (TCO) 故事，并执行严谨的管道和定价策略。与临床医生、医疗系统和经销商建立值得信赖的伙伴关係，仍将是加速产品采用和减少采购摩擦的关键差异化因素。随着临床路径的演变以及新型能量模式和栓塞化学疗法的日益普及，持续投资于上市后数据收集、培训和数位化准备将保持竞争优势。

最终，临床需求、监管预期和商业性敏捷性的相互作用将决定未来发展方向。相关人员将研发重点与成熟的医疗体系价值观结合，并投资于营运韧性，将最有可能实现持久的临床和商业性影响。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 整合基于人工智慧的影像引导系统，提供即时程式决策支持
  • 开发可生物吸收的栓塞材料，最大限度地减少长期血管阻塞
  • 采用紧凑型 C 臂成像系统，提升移动套件的便携性
  • 利用微波和雷射技术扩展微创肿瘤切除设备
  • 整合先进的 3D 列印技术，用于患者特定的血管模型和设备规划
  • 由于安全法规更加严格，对辐射剂量减少技术的需求激增
  • 用于治疗动静脉畸形 (AVM) 的聚合性和非黏附性液体栓塞系统的快速成长
  • 新兴机器人导管导航平台提高了复杂干预的精确度

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 介入放射学产品市场​​（依产品类型）

  • 消融设备
    • 微波消融装置
    • 射频消融术装置
  • 血管成形术用气球
  • 导管
  • 栓塞剂
    • 液体栓子
    • 颗粒栓塞
  • 栓塞线圈
  • 导管导引线
  • 血管闭合装置
  • 血管支架
    • 颈动脉支架
    • 週边血管支架

9. 介入性放射学产品市场​​（按应用）

  • 神经介入
    • 动脉瘤栓塞
    • 中风血栓切除术
  • 肿瘤干预
    • 经动脉化疗栓塞术
    • 肿瘤消融
      • 冷冻疗法
      • 微波消融装置
      • 射频消融术装置
  • 疼痛管理
  • 血管介入

第 10 章介入放射学产品市场​​（依最终用户划分）

  • 门诊手术中心
  • 诊所
  • 医院

第 11 章介入放射学产品市场​​（依分销通路）

  • 直销
  • 经销商销售

12. 介入性放射学产品市场​​（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 13 章介入放射学产品市场​​（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章。 介入性放射学产品市场​​（按国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Boston Scientific Corporation
    • Medtronic plc
    • Siemens Healthineers AG
    • GE HealthCare Technologies, Inc.
    • Koninklijke Philips NV
    • Terumo Corporation
    • Cook Medical LLC
    • Cardinal Health, Inc.
    • Guerbet SA
    • Merit Medical Systems, Inc.
Product Code: MRR-46132FF7A845

The Interventional Radiology Products Market is projected to grow by USD 19.88 billion at a CAGR of 6.60% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 11.92 billion
Estimated Year [2025] USD 12.70 billion
Forecast Year [2032] USD 19.88 billion
CAGR (%) 6.60%

An authoritative introduction to how device innovation, clinical demand, and care setting shifts are reshaping the interventional radiology ecosystem globally

Interventional radiology continues to evolve at the intersection of clinical need, device innovation, and health system transformation. Minimally invasive techniques now address a broader range of pathologies, driven by advances in imaging, energy delivery, and embolic chemistries. Clinicians increasingly prefer targeted interventions that reduce procedural morbidity and shorten recovery time, which in turn redefines demand across the spectrum of devices used in the catheterization laboratory and hybrid suites.

This narrative encompasses a diverse product landscape that includes thermal ablation platforms, angioplasty balloons, catheters, embolic agents, embolization coils, guidewires, vascular closure systems, and stent technologies. Within these categories, sub-specialized modalities such as microwave and radiofrequency ablation, liquid and particulate embolics, and carotid versus peripheral stent designs create distinct clinical value propositions. Applications span neurovascular procedures through aneurysm management and stroke thrombectomy, oncology interventions via transarterial chemoembolization and tumor ablation, pain management techniques, and a broad range of vascular interventions.

End users vary from hospitals to ambulatory surgical centers and clinics, each presenting unique procedural volumes, purchasing behaviors, and capital equipment constraints. Distribution pathways that rely on either direct sales models or distributor networks further shape product adoption curves. Taken together, these elements form the foundation for the analysis that follows, setting context for how device innovation, care setting migration, and commercialization strategies will determine competitive advantage and clinical impact.

How image-guided innovation, outpatient migration, digital integration, and supply chain resilience are collectively transforming clinical adoption and commercial strategy

Several transformative shifts are redefining the interventional radiology landscape and altering the trajectory of product development and commercialization. First, the maturation of image guidance and navigation systems has elevated procedural precision, enabling smaller devices and more complex anatomies to be treated safely. Concurrently, energy delivery modalities and embolic materials are becoming more sophisticated, which supports a movement from single-use instruments toward integrated therapy platforms that combine imaging, ablation, and embolization capabilities.

The migration of procedures to outpatient settings and ambulatory surgical environments is accelerating demand for compact, cost-efficient systems and streamlined workflows. This transition interacts with end-user purchasing preferences and capital allocation, prompting manufacturers to rethink product form factors and service models. At the same time, digital augmentation, including procedure analytics and device connectivity, is emerging as a differentiator for long-term clinician engagement and post-market surveillance.

Supply chain resilience and regulatory expectations are also shifting. Manufacturers are investing in regional manufacturing and quality systems to reduce exposure to disruptions, and health systems are demanding stronger evidence of clinical benefit and cost-effectiveness. These changes create both constraints and opportunities: they compress time-to-adoption for solutions that demonstrate clear value while increasing barriers for commoditized products without differentiated clinical advantage.

Assessing how cumulative tariff shifts have catalyzed regional manufacturing strategies, pricing pressure, and procurement behaviors across the interventional device value chain

Recent tariff dynamics have exerted a cumulative impact on the interventional device value chain, prompting manufacturers and purchasers to reassess sourcing and cost structures. Increased duties and trade frictions raise the landed cost of imported components and finished products, which places pressure on manufacturers to re-evaluate supplier networks, materials choice, and regional manufacturing footprints. As a result, organizations face a strategic choice between absorbing higher unit costs, re-engineering products for alternative components, or shifting production closer to end markets.

These pressures ripple through distribution models: direct sales organizations may confront margin compression and longer procurement cycles as hospitals and ambulatory centers scrutinize purchased capital, while distributor-led channels contend with inventory re-pricing and contractual renegotiations. Clinicians and procurement teams respond by prioritizing multi-functional platforms and solutions that reduce procedure time and overall episode cost, thereby offsetting device price inflation with demonstrable clinical and economic benefits.

In response, manufacturers can adopt adaptive pricing strategies, secure longer-term supply agreements, and pursue localized manufacturing partnerships to stabilize cost structures. Meanwhile, stronger clinical evidence and outcomes documentation become essential tools to defend pricing and justify product selection during procurement deliberations. Collectively, these responses shape a more resilient and regionally balanced manufacturing and commercial model for interventional devices.

Key segmentation insights outlining how product modalities, clinical applications, care settings, and distribution dynamics intersect to shape adoption and commercialization

Detailed segmentation reveals where clinical demand and commercial opportunity converge across product types, applications, end-user channels, and distribution pathways. From a product perspective, thermal ablation devices coexist with a broad array of vascular tools: microwave and radiofrequency systems deliver distinct ablative profiles that influence tumor ablation protocols, while angioplasty balloons, catheters, guidewires, and stents address mechanical revascularization needs. Embolic therapies vary between liquid embolics that enable distal penetration and particulate agents that provide calibrated occlusion, and stent designs differentiate between carotid protection and peripheral vessel scaffolding.

Application-driven dynamics show that neuro interventions such as aneurysm embolization and stroke thrombectomy require ultra-high reliability and rapid device availability, whereas oncology interventions leverage both transarterial chemoembolization and tumor ablation approaches that depend on synergy between embolic materials and energy sources. Pain management procedures demand precise lesion targeting with minimal collateral tissue damage, and vascular interventions span a wide spectrum of acute and chronic indications that influence device specifications and adjunctive therapies.

End users exhibit divergent purchasing behaviors and procedural settings. Hospitals typically favor comprehensive platforms with full-service support, ambulatory surgical centers seek compact and cost-effective systems optimized for throughput, and clinics focus on devices that enable same-day procedures with predictable outcomes. Distribution choices between direct sales and distributor networks affect post-sale service expectations, training commitments, and inventory management, shaping how manufacturers structure commercial operations and training investments.

Regional intelligence that connects clinical demand, regulatory complexity, and manufacturing priorities to actionable commercialization pathways across key global markets

Regional dynamics exert a powerful influence on device design, regulatory strategy, and commercial planning. In the Americas, health systems are increasingly focused on value-based care and outpatient migration, driving demand for devices that demonstrate cost-efficiency and procedural throughput gains. The payer landscape encourages rigorous outcomes data to support inclusion in care pathways, and the scale of large health systems emphasizes purchasing partnerships that include training and long-term service agreements.

Across Europe, Middle East & Africa, the regulatory environment and reimbursement architectures present a mosaic of requirements that reward clinical evidence and interoperability. Procurement cycles can be longer and more fragmented, but opportunities exist for devices that meet diverse clinical needs while conforming to regional standards and local manufacturing expectations. In addition, healthcare capacity constraints in some markets accelerate adoption of less invasive therapies that reduce hospital stay and intensive care utilization.

Asia-Pacific is characterized by rapid infrastructure investment, expanding procedural volumes, and a growing middle-class demand for advanced therapies. Local manufacturing capabilities and partnerships often determine market access, and agility in pricing and service models can be a decisive differentiator. Across all regions, pragmatic localization of clinical evidence, regulatory dossiers, and supply chain strategies remains essential to converting clinical interest into sustained adoption.

Corporate and competitive intelligence showing how platform strategies, partnerships, and evidence-led commercialization determine sustainable advantage in interventional device markets

Corporate strategies are increasingly centered on platform consolidation, focused R&D investment, and selective partnerships that accelerate time to clinical adoption. Leading organizations prioritize cross-functional portfolios that integrate imaging, therapy delivery, and data services, while emerging companies target niche indications where technical differentiation and clinical need intersect. Collaboration between device OEMs and software providers is expanding, yielding connected solutions that support procedural planning, intra-procedural guidance, and post-market outcomes tracking.

Mergers and acquisitions remain a tactical route to acquire complementary technologies and receptive customer bases, but acquirers emphasize fit with existing service models and regulatory footprints. Contract manufacturing and strategic outsourcing reduce capital intensity but require rigorous quality oversight to maintain device reliability. Companies that invest early in clinical evidence generation and in-field training resources tend to secure durable clinician loyalty and smoother procurement approvals.

From a commercial perspective, firms that align pricing models with documented reductions in procedure time, hospital stay, or repeat interventions create stronger value propositions. Additionally, organizations that build scalable support infrastructures for ambulatory settings and clinics capture growth as care migrates out of traditional hospitals. Ultimately, corporate agility in R&D prioritization, channel management, and evidence development determines competitive positioning in this evolving marketplace.

Actionable strategic recommendations for industry leaders to build supply resilience, accelerate outpatient adoption, and monetize evidence-driven clinical value

Industry leaders should prioritize a set of pragmatic actions that balance short-term resilience with long-term growth. First, diversify manufacturing and supply chain footprints to reduce exposure to trade disruptions and to accommodate localized regulatory requirements. This strategy should include dual sourcing of critical components, selective nearshoring for high-risk items, and collaborative supplier risk-sharing arrangements to protect continuity of supply.

Second, invest in clinical evidence generation that clearly ties device performance to patient outcomes and total episode-of-care economics. High-quality registries, pragmatic clinical trials, and strong post-market surveillance enable more effective reimbursement conversations and support adoption in value-oriented health systems. Third, reconfigure product portfolios to address the outpatient migration trend by developing compact, service-light platforms that maintain clinical efficacy while reducing capital and operational burden for ambulatory centers and clinics.

Fourth, strengthen channel strategies by calibrating direct sales and distributor models to regional market realities, ensuring training and service capabilities match end-user expectations. Fifth, leverage digital tools for procedure analytics, remote training, and device connectivity to deepen clinician engagement and to create recurring service revenue. Finally, adopt adaptive pricing and contracting frameworks that align commercial terms with demonstrated clinical value, enabling more predictable procurement outcomes in price-sensitive environments.

A transparent, clinician-anchored methodology blending primary stakeholder engagement, secondary evidence synthesis, and rigorous triangulation to validate strategic insights

The research methodology combines primary qualitative engagement, secondary data integration, and rigorous triangulation to ensure findings are grounded in both clinical reality and commercial practice. Primary inputs include structured interviews with practicing interventionalists, procurement leaders, hospital administrators, ambulatory surgical center operators, and distributor partners to capture firsthand perspectives on clinical needs, purchasing drivers, and service expectations. Expert panels and clinician advisory boards provide validation of clinical trends and device performance characteristics.

Secondary research synthesizes peer-reviewed literature, clinical registries, regulatory filings, and product technical documentation to map technology attributes and historical adoption trajectories. Where available, procedure coding trends and published outcomes data inform the assessment of clinical pathways, while analyses of supply chain flows and trade patterns support evaluation of manufacturing and distribution risk. Data are cross-validated through multiple sources and reconciled with primary stakeholder feedback to reduce bias.

The segmentation framework is applied systematically across product, application, end-user, and distribution dimensions to identify areas of convergence between clinical need and commercial feasibility. Limitations and assumptions are documented transparently, and sensitivity checks are performed to test how alternative scenarios affect strategic implications. Ongoing stakeholder engagement is recommended to refine insights as new clinical evidence and policy developments emerge.

A decisive conclusion synthesizing clinical, commercial, and operational vectors that define winning strategies in the evolving landscape of interventional therapies

The collective analysis underscores a market in active transition, characterized by technological refinement, migration of care to lower-cost settings, and a need for resilient commercial and manufacturing models. Device innovation that couples procedural efficacy with operational efficiency will command heightened interest from clinicians and procurement teams alike. At the same time, geopolitical and trade considerations have elevated the importance of diversified supply chains and regionally attuned go-to-market strategies.

Success will favor organizations that combine robust clinical evidence with adaptable product platforms, deliver compelling total cost-of-care narratives, and execute disciplined channel and pricing strategies. Building trusted partnerships with clinicians, health systems, and distributors remains a critical differentiator that accelerates adoption and mitigates procurement friction. As clinical pathways evolve and new energy modalities and embolic chemistries gain traction, continuous investment in post-market data collection, training, and digital enablement will sustain competitive positioning.

Ultimately, the interplay of clinical need, regulatory expectations, and commercial agility defines the path forward. Stakeholders who align R&D priorities with demonstrated health system value and who invest in operational resilience will be best positioned to capture enduring clinical and commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-based image guidance systems for real-time procedural decision support
  • 5.2. Development of bioresorbable embolic materials to minimize long-term vessel blockages
  • 5.3. Adoption of compact C-arm imaging systems for enhanced portability in mobile suites
  • 5.4. Expansion of minimally invasive tumor ablation devices using microwave and laser technologies
  • 5.5. Integration of advanced 3D printing for patient-specific vascular phantoms and device planning
  • 5.6. Surge in demand for radiation dose reduction technologies to comply with stricter safety regulations
  • 5.7. Rapid growth of liquid embolic systems incorporating polymerizable and nonadhesive agents for AVM treatment
  • 5.8. Emergence of robotic catheter navigation platforms to improve precision in complex interventions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Interventional Radiology Products Market, by Product Type

  • 8.1. Ablation Devices
    • 8.1.1. Microwave Ablation Devices
    • 8.1.2. Radiofrequency Ablation Devices
  • 8.2. Angioplasty Balloons
  • 8.3. Catheters
  • 8.4. Embolic Agents
    • 8.4.1. Liquid Embolics
    • 8.4.2. Particulate Embolics
  • 8.5. Embolization Coils
  • 8.6. Guidewires
  • 8.7. Vascular Closure Devices
  • 8.8. Vascular Stents
    • 8.8.1. Carotid Stents
    • 8.8.2. Peripheral Vascular Stents

9. Interventional Radiology Products Market, by Application

  • 9.1. Neuro Intervention
    • 9.1.1. Aneurysm Embolization
    • 9.1.2. Stroke Thrombectomy
  • 9.2. Oncology Intervention
    • 9.2.1. Transarterial Chemoembolization
    • 9.2.2. Tumor Ablation
      • 9.2.2.1. Cryoablation
      • 9.2.2.2. Microwave Ablation Devices
      • 9.2.2.3. Radiofrequency Ablation Devices
  • 9.3. Pain Management
  • 9.4. Vascular Intervention

10. Interventional Radiology Products Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Interventional Radiology Products Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales

12. Interventional Radiology Products Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Interventional Radiology Products Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Interventional Radiology Products Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Boston Scientific Corporation
    • 15.3.2. Medtronic plc
    • 15.3.3. Siemens Healthineers AG
    • 15.3.4. GE HealthCare Technologies, Inc.
    • 15.3.5. Koninklijke Philips N.V.
    • 15.3.6. Terumo Corporation
    • 15.3.7. Cook Medical LLC
    • 15.3.8. Cardinal Health, Inc.
    • 15.3.9. Guerbet S.A.
    • 15.3.10. Merit Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL R